Johnsen, H E <br/><br/>
Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.  [electronic resource] 

 -  Experimental hematology  Jan 1994 
 - 80-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0301-472X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD--analysis<br/>Antigens, CD34<br/>Bone Marrow--drug effects<br/>Cell Division--physiology<br/>Cytokines--pharmacology<br/>Dose-Response Relationship, Drug<br/>Erythropoietin--pharmacology<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Interleukin-3--pharmacology<br/>Leukemia--pathology<br/>Recombinant Proteins--pharmacology<br/>Time Factors<br/>Tumor Cells, Cultured--drug effects